Loading...
Loading...
By Anmol Motwani - Mon, 06/03/2024 - 09:28
The US FDA approved Moderna's mResvia for adults over 60, which shows 79% effectiveness in protecting against respiratory syncytial virus (RSV).
Featured content
Partnership Content
